I think another thing to keep an eye on this HY will be just how much FCF they produced. From their quarterlies it looks like they were able to build their cash (particularly in Q2). Getting to see the accounts should confirm this.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor